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Background: Health-related quality of life (HR-QoL) of patients with heart failure (HF) is low 
despite the aim of HF-treatment to improve HR-QoL. To date, most studies have focused on 
medical and physical factors in relation to HR-QoL, little data is available on the role of 
emotional factors like dispositional optimism. This study examines the prevalence of 
optimism and pessimism in HF-patients and investigates how optimism and pessimism are 
associated with different patient characteristics and HR-QoL.  
Methods and results: Dispositional optimism was assessed in 86 HF-patients (mean age 70 ± 
9 years, 28% female, mean left ventricular ejection fraction [LVEF] 33%) with the Revised Life 
Orientation Test (LOT-R). HR-QoL was assessed with the Minnesota Living with Heart Failure 
Questionnaire and the EuroQol. The (mean ± SD) total score on the LOT-R was 14.6±2.9 
(theoretical range 0-24), the scores on the subscales optimism and pessimism were 8.1±1.9 
and 5.5±2.5, respectively. Higher age was related to more optimism (r=0.22, p<0.05), and 
optimism was associated with higher generic HR-QoL (B = 0.04, p<0.05).  
Conclusion: The association found between optimism and generic HR-QoL of HF patients can 
lead to promising strategies to improve HF patients’ HR-QoL, particularly since the literature 
has indicated that optimism is a modifiable condition. 
  
Introduction 
Important objectives of HF treatment are symptom relief and improvement of health-related 
quality of life (HR-QoL).1 Despite these objectives, HR-QoL of HF patients is seriously reduced 
compared with both a normative population2 and patients suffering from other diseases.3 
Due to an increasing body of research on HR-QoL, more knowledge of how to improve HR-
QoL is available. Previous research has focused mainly on medical and physical factors related 
to HR-QoL;4-9 however, emotional factors10 such as depressive symptoms are also highly 
prevalent in patients with HF 11,12 and are related to HR-QoL.13 HF patients with a comorbid 
depressive disorder, for example, have a lower HR-QoL compared with HF patients without a 
comorbid depressive disorder. Interventions that aim to improve the depressive disorder are 
able to increase HR-QoL of these HF patients.13 Psychosocial and existential concerns are 
important aspects of the lives of patients suffering from heart failure. 14 Personality factors, 
including dispositional optimism, can therefore affect how patients report on their health 
status 15 and their HR-QoL.16 Dispositional optimism can be defined as the tendency to expect 
positive outcomes across a variety of life domains.15 Common definitions indicate that 
pessimism is an antonym for optimism. Some investigators agree with this view, and tend to 
adopt optimism as a unidimension, classifying pessimism as the opposite end of optimism.17 
Within this context, the measure of optimism is constructed so that an optimistic outlook 
necessarily precludes a pessimistic outlook, and vica versa.18 However, other researcher 
suggest that endorsing items that reflect an optimistic perspective is substantively different 
from disagreeing with items that reflect a pessimistic outlook.19 If this is true, then optimism 
and pessimism would not represent opposite ends of a single continuum, but should be 
considered separate and, to some meaningful extent, independent constructs. Until today, 
  
there is little consensus on the issue of pessimism being the opposite of optimism or being an 
independent construct.18  
Optimism has been associated with favorable health outcomes and quality of life.20 
Pessimism on the other hand, has shown to be prospectively related to poor self-rated health 
and impaired psychological well-being.21 In addition, a recent study showed that optimism is 
associated with a lower risk of developing heart failure.22 However, the relation between 
optimism and pessimism and HR-QoL has not yet been examined in HF patients. 
Although dispositional optimism is supposed to be a relatively stable construct, several 
studies have found that dispositional optimism is a modifiable condition.18-20 Higher levels of 
dispositional optimism can be achieved by means of psychological interventions,23-25 and such 
interventions may also improve HR-QoL of HF patients. In addition, there is a considerable 
amount of data on dispositional optimism in cancer patients showing that optimists have a 
better global HR-QoL than pessimists.23,26-28 Several studies that examined how patients cope 
with a life threatening disease such as cancer found remarkable differences between 
individuals regarding health outcomes and HR-QoL, depending on their psychological 
adjustment to stress.29,30 Older HF patients, for example, were found to be able to adapt their 
personal expectations to such an extent that they positively influenced their HR-QoL.31  
In order to develop new interventions to improve HR-QoL of HF patients, it is 
important to examine the relationship between optimism and pessimism and HR-QoL of HF 
patients. Therefore, the present study aims to (1) describe the prevalence of optimism and 
pessimism in HF patients, (2) examine the association between clinical and demographic 
patient characteristics and optimism and pessimism, and (3) describe the relationship 





A descriptive cross-sectional study was performed. In total, 159 outpatients who visited the 
HF clinic of the University Medical Center Groningen in the Netherlands between January 
2012 and July 2012 were asked to participate in the study. Inclusion criteria were having a 
diagnosis of HF (independent of LVEF) New York Heart Association functional (NYHA) 
classification I-IV and being aged 50 or over. Patients with impaired cognition, inability to 
speak the Dutch language, or inability to understand informed consent as determined by the 
HF nurse were excluded from participation. Fifty-six patients declined to participate in the 
study. Of the enrolled patients, a further three patients were excluded from the analysis 
because they were not able to pass a test question necessary to complete a study assessment 
on patients’ preferences which was also part of the data collection. 32 The study activities 
were combined with routine visits to the HF outpatient clinic, and the questionnaires were 
administrated by trained researchers who were not involved in the treatment of the included 
patients. The study was part of a larger study on HF patients’ preferences.32 The study 
conforms to the principles outlined in the Declaration of Helsinki. The Medical Ethics 
Committee approved the study protocol, and all enrolled patients provided their written 




Dispositional optimism was assessed with the Revised Life Orientation Test (LOT-R),33 which 
is a widely used instrument in psychological research and which has good psychometric 
properties (e.g. Cronbach’s alpha of .71 for the total score, and .64 and .77 for the optimism 
  
and pessimism subscale scores).15,33,34 The LOT-R consists of 10 items: three items are 
positively worded, three items are negatively worded, and four items are filler items. The 
respondents are asked to indicate their agreement on a 5-point Likert scale with response 
categories ranging from strongly agree to strongly disagree. Although originally composed as 
a unidimensional scale, some studies suggest a bidimensionality of two independent factors: 
optimism and pessimism.21,34-36 Therefore, in this study, both the total score and the subscale 
scores on optimism and pessimism were used. The total score was calculated by summing the 
three positively worded items and the reverse-coded, negatively worded items. Scores on the 
LOT-R range from 0 to 24, with higher scores indicating more optimism. The optimism 
subscale score was calculated by summing the three positively worded items; the pessimism 
subscale score was calculated by summing the raw scores on the negatively worded items. 
Both subscales have a scoring range of 0 to 12, with higher scores indicating more optimism 
or more pessimism. Norm scores are not available for the LOT-R. The Cronbach’s alpha in our 
study sample was .33 for the total score, .40 for the optimism subscale score and .60 for the 
pessimism subscale score.  
 
Health-related quality of life 
HR-QoL was assessed with a disease-specific (the Minnesota Living with Heart Failure 
Questionnaire [MLHFQ]) and a generic instrument (EuroQol [EQ-5D]). The MLHFQ is a widely 
used disease-specific questionnaire in HF research37,38 with good psychometric properties.37 
The MLHFQ has a total score ranging from 0 to a maximum of 105 and consists of two 
domains: a physical component and an emotional component, with 40 and 25 as maximum 
possible scores, respectively. Lower scores on the MLFHQ reflect better HR-QoL.39 Norm 
scores are not available for the MLHFQ.  
  
The EQ-5D is designed for use across a wide range of health interventions40 and is 
frequently used in cardiovascular trials.41 The EQ-5D consists of 5 domains: mobility, self-care, 
usual activities, pain/ discomfort, and anxiety/ depression. Each domain has three levels: no 
problems, some problems, and severe problems. The scoring is based on the British tariff,42 
and values theoretically fall on the 0.0 (dead) to 1.0 (perfect health) value scale. Negative 
scores may occur, meaning that that particular health state is valued as worse than dead 
(from a societal perspective). Norm scores are available for the EQ-5D: male (70-74 years) 
+0.77, female +0.75.43 Higher scores reflect better HR-QoL. In addition to the 5 domains, the 
EQ-5D contains an EQ visual analogue scale (EQ VAS), which records the respondent’s self-
rated health on a vertical scale from 0 to 100. Norm scores for the EQ VAS are 77.70 for males 
and 74.05 for females.43 
 
Background characteristics 
Demographic (age, gender, education) and clinical data (medical history, disease state) were 
collected from patient interviews and from patients’ medical charts.  
 
Statistical analyses 
Descriptive analyses were used to characterize the patient sample. Data are presented as 
means ± standard deviations or frequencies (percentages). Bivariate analyses, Mann-Whitney 
U test, and Spearman’s correlation coefficient, as appropriate, were performed to evaluate 
the relationship between background characteristics and the LOT-R (total and subscale) 
scores. Linear multiple regression analyses per subscale and total score were performed to 
determine whether the total score of the LOT-R, the optimism subscale and the pessimism 
subscale as independent variables were associated with quality of life as a dependent 
  
variable. In the first block, only the  LOT-R (total or subscale) score and HR-QoL scores were 
entered using the enter method. Based on univariate associations with p < 0.10 between the 
background characteristics and the LOT-R (total and subscale) scores, background 
characteristic variables were inserted in the final adjusted regression model in addition to the 
HR-QoL scores. This resulted in adding the variables ‘living alone’ and ‘being religious’ in the 
adjusted model for the LOT-R total score, the variables ‘age’ and ‘having had a resuscitation 
in the past’ in the adjusted model for the LOT-R optimism subscale score and the variables 
‘COPD’ and ‘hypertension’ in the adjusted model for the LOT-R pessimism subscale score.  
Analyses were performed using SPSS version 18.0.3 for Windows. Outcomes were considered 





A total of 100 patients were included in this study. Fourteen patients were excluded from the 
analysis because they could not complete the questionnaire in time during the interview. The 
mean age of the patients was 70 ± 9 years, and 28% (n = 24) of the patients were female 
(Table 1). Patients had a mean LVEF of 33% ± 12%, and 35% (n = 30) of the patients were 
classified as NYHA functional class III-IV. 
 
Dispositional optimism and health-related quality of life 
The mean total score on the LOT-R was 14.6 ± 2.9. The mean scores on the LOT-R optimism 
subscale and pessimism subscale were 8.1 ± 1.9 and 5.5 ± 2.5, respectively (Table 2).  
  
The mean total score on the MLHFQ was 30 ± 23. The mean scores on the physical and 
emotional components were 14 ± 12 and 6 ± 6, respectively. The mean score on the EQ-5D 
was 0.66 ± 0.28 and the EQ VAS 68 ± 46 (Table 2). 
 
Relationship between dispositional optimism and pessimism and demographic and clinical 
variables  
None of the independent variables were significantly related to the LOT-R total score (p < 
0.05); however, there was a non-significant trend that not living alone and being religious 
were related to more dispositional optimism (patients who live alone [mean score 13.7] vs. 
patients who do not live alone [mean score 14.9] U = 533, p<0.10 and patients who are 
religious [mean score 15.2] vs. patients who are not religious [mean score 14.2] U = 704, 
p<0.10). Regarding the optimism subscale, having a higher age was related to more optimism 
(r = 0.22, p<0.05). Regarding the pessimism subscale, having COPD or hypertension as a 
comorbidity was associated with more pessimism (having COPD (mean score 6.6) vs. not 
having COPD (mean score 5.1) U = 461, p<0.05 and having hypertension (mean score 6.0) vs. 
not having hypertension (mean score 5.0) U = 690, p<0.05) (Table 3). 
 
Relationship between dispositional optimism and pessimism and health-related quality of 
life 
The optimism subscale of the LOT-R was significantly associated with HR-QoL when measured 
with the generic EQ-5D, but it was not significantly associated with HRQL when measured 
with the disease-specific MLHFQ. In the adjusted model (adjusted for variables associated 
with the LOT-R scores with a p-value < 0.10), the optimism subscale score remained 
significantly associated with the dimensions of the EQ-5D and the EQ-VAS score. The score on 
  
the pessimism subscale and total score on the LOT-R were not associated with the EQ-5D or 




This is the first study to examine the relationship between dispositional optimism and HR-QoL 
of outpatients with HF. We found that higher age was associated with more optimism and 
that having COPD or hypertension was associated with more pessimism, as measured with 
the subscales of the LOT-R. In addition, we found independent associations between 
optimism and generic HR-QoL and between optimism and EQ-VAS, indicating that being more 
optimistic is related to a better HR-QoL. Independent associations were only found between 
generic HR-QoL and optimism, not between disease-specific HR-QoL and optimism. It could 
be that the MLFHQ was not sensitive enough in this population because of the small sample 
size of the study population.44 
The scores on the LOT-R of our study population are difficult to compare with the 
scores reported in other studies because only one study has used the LOT-R in HF patients 
before.45 The levels of optimism in our study population were lower than those found in the 
study of Giardini, 45 which might be explained by the higher age of the patients in our study. 
The HF patients in our study were slightly less optimistic compared with coronary bypass 
surgery33 patients and urogenital cancer patients.35 However, they were less pessimistic 
compared with patients with urogenital cancer.  
Optimism is related to quality of life and this may be useful for future interventions. 
Because HF has a poor prognosis and causes severe symptoms, alternative ways to improve 
the HR-QoL of HF patients need to be further explored. Several studies in cancer patients 
  
found that optimists had a better global HR-QoL than pessimists.23,26-28 A systematic review 
on psychosocial interventions for cancer patients46 found two intervention studies with a 
moderating effect on dispositional optimism. After a cognitive-behavioral stress management 
intervention, women who showed lower levels of optimism prior to the intervention reported 
enhanced optimism relative to those who had higher levels of optimism prior to the 
intervention.47 Another study48 found the moderating effect of psychosocial factors, including 
dispositional optimism, after a nutrition-focused psychoeducation program. 
Healthcare providers may wish to identify those patients who are at risk of being 
pessimistic since this may affect their HR-QoL. We found that the comorbidities COPD or 
hypertension were associated with more pessimism. The literature suggests that 
comorbidities also affect HR-QoL of patients with HF.2 The comorbidities COPD and 
hypertension are frequently found in HF patients, and treatments are needed that target both 
these comorbidities and HF.49 Furthermore, more research is necessary to explore the 
association between hypertension and pessimism in depth, as hypertension is usually a 
diagnosis with relatively low complaints compared to the diagnosis COPD. 
However, at the same time we realize that interventions aimed directly at improving 
optimism are scarce, which makes it difficult to indicate what psychological care for patients 
with lower levels of optimism should look like. Applebaum50 speculates that the incorporation 
of screening for optimism – among other variables – into routine clinical care will allow for 
the prompt identification and referral of patients with low levels of optimism and social 
support to psychosocial programs that either directly provide (e.g., through group 
psychotherapy) or facilitate social support and promote the recognition of the possibility of 
the benefit and growth despite suffering. This may serve as a protective factor against 
  
psychopathology. A recent systematic review of the influence of psychological factors on HR-
QoL after a stroke also confirms the need for more research on optimism.51  
Since our study is one of the first to address dispositional optimism and HR-QoL more 
research is needed to be able to develop promising psychological interventions and to identify 
those patients who will benefit from these interventions. 
Limitations of this study are its cross-sectional nature and the small sample size. More 
non-interventional research on a larger population of patients in routine care is indicated and 
would strengthen the results of future studies. Furthermore, the independent association 
between optimism and general HR-QoL could be refined further in a larger study population 
when the patients are assigned to different groups depending on for example there LVEF and/ 
or severity of HF symptoms (NYHA-classification). We could not compare the clinical 
characteristics of the patients who participated with those who refused to participate 
because we did not have the latter group’s signed informed consent. Nevertheless, the 
demographic and clinical parameters of our study population are comparable with those of 
the population in our HF patient clinic and other main studies.52,53 In our study we did not 
collect information whether the patients underwent previous CABG treatment or whether 
they suffered from dyslipidemia, these factors might also have an impact on the scores of the 




This study provides new insights into dispositional optimism in patients with HF and is, to our 
knowledge, the first study to explore the relationship between dispositional optimism and 
HR-QoL of patients with HF. This study found a relationship between optimism and HR-QoL 
  
of patients with HF. Given that the literature has suggested that optimism is a modifiable 
condition, improving optimism may be a promising way to improve HR-QoL of HF patients. 
However, more research is needed to assess which patients will benefit from psychological 




Table 1. Demographic and clinical characteristics of the study population (n = 86). 
 Study population 
(n = 86) 
Patient characteristics  
Age (years) 70 (±9) 
Gender (female) 28% (24) 
Living alone 26% (22) 
Being Religious  42% (36)  
Clinical characteristics  
LVEF % 33 (±12) 
NYHA III-IV  35% (30) 




eGFR (ml/min*1.73m2) 53.6 (±20.0) 
NT-pro-BNP (ug/l) (IQR) 1055 (421-3082) 
Ischemic heart failure 58%(50) 
ICD implantation 41% (35) 
Resuscitation in the past 11% (9)  
Myocardial infarction 51% (44) 
Duration of heart failure (years) 2.6 (±3.4) 




26% (22)  
Diabetes Mellitus 28% (24) 
Stroke 12% (10) 
Hypertension 55% (47) 
Cancer  6% (5)  
Note: 
Mean (±SD), percentage (number) or median (minimum-maximum) 
HF = heart failure; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association; eGFR = 
estimated globular filtration rate; NT-pro-BNP = N-terminal prohormone of brain natriuretic peptide; IQR = 





Table 2. Optimism- and health-related quality of life scores of the study population (N = 86) 
 Study population 
(n = 86) 
Optimism  
LOT-R   
Total score 14.6 ± 2.9  
Optimism subscale score 8.1 ± 1.9  
Pessimism subscale scores 5.5 ± 2.5  
Health-related quality of life  
MLHFQ  
Total score  30 (±23) 
Physical component 14 (±12) 
Emotional component 6 (±6) 
EQ-5D 0.66 (±0.28) 
EQ VAS 68 (±46) 
Note: 
Mean (±SD); LOT-R = Life Orientation Test-Revised; MLHFQ = Minnesota Living with Heart Failure 
Questionnaire; EQ-5D = EuroQol-5 Dimensions; EQ VAS = EuroQoL visual analogue scale. 
Optimism total score/ optimism subscale/pessimism subscale: higher scores reflecting more dispositional 
optimism/ optimism/pessimism. 
MLHFQ total score and subscales: lower scores reflecting better HR-QoL 




Table 3. Univariate associations between optimism and pessimism and demographic and clinical characteristics 
(N = 86) 
 LOT-R 
 Total Optimism Pessimism 
Patient characteristics    
Age (years) 0.02 **0.22 0.13 
Gender  659 714 675 
Living alone *533 611 579 
Being religious *704 812 751 
Clinical characteristics    
LVEF % -0.01 -0.08 -0.10 
NYHAIII-IV 783 839 804 
Ischemic heart failure 839 793 862 
Myocardial infarction 882 862 900 
ICD implantation 769 815 767 
Resuscitation in the past 267 *232 346 
Duration of heart failure (years) -0.01 0.04 0.04 
HF readmission in last 6 months  752 710 767 
Laboratory:    
eGFR (ml/min*1.73m2) -0.02 0.02 0.05 
NT-pro-BNP (ug/l) -0.02 0.02 0.06 
Comorbidities:    
COPD 553 668 **461 
Diabetes Mellitus 692 675 631 
Stroke 379 352 361 
Hypertension 730 885 **690 
Cancer 145 141 117 
Note: 
Data are presented as U for categorical independent variables and r for continues independent variables 
* p<0.10, ** p<0.05 
HF = heart failure; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association; ICD = internal 
cardiac defibrillator; eGFR = estimated globular filtration rate; NT-pro-BNP = N-terminal prohormone of brain 










Table 4. Multivariate associations between optimism, pessimism, and health related quality of life (HR-QoL) (N=86). 
LOT-R 
 Total Optimism Pessimism 
 B SE p-value B SE p-value B SE p-value 
MLHFQ          
Total score  -0.05 0.90 0.95 -1.81 1.40 0.20 -0.94 1.05 0.38 
Total score adjusted model* 0.62 0.86 0.48 -0.79 1.28 0.54 -1.15 0.98 0.24 
Physical component -0.16 0.44 0.71 -0.78 0.70 0.27 -0.20 0.52 0.71 
Physical component adjusted model* 0.01 0.42 0.99 -0.51 0.63 0.43 -0.31 0.50 0.54 
Emotional component -0.04 0.21 0.85 -0.62 0.32 0.06 -0.30 0.24 0.23 
Emotional component adjusted model* -0.05 0.19 0.81 -0.45 0.29 0.13 -0.08 0.23 0.73 
EQ-5D          
Dimensions 0.01 0.01 0.22 0.04 0.02 0.03 0.00 0.01 0.82 
Dimensions adjusted model* 0.02 0.01 0.09 0.04 0.02 0.02 0.00 0.01 0.86 
EQ VAS  0.55 0.61 0.37 2.92 0.90 < 0.01 0.90 0.71 0.21 
EQ VAS adjusted model* 0.33 0.61 0.59 2.50 0.92 < 0.01 0.85 0.77 0.27 
Note: 
LOT-R = Life Orientation Test-Revised; MLHFQ = Minnesota Living with Heart Failure Questionnaire; EQ-5D = EuroQol-5 Dimensions; EQ VAS = EuroQoL Visual Analogue 
Scale. 
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